Patients suffering from several mental conditions such as depression, anxiety, schizophrenia
Already popular on the online peptide gray market, the new drug, originally developed by Eli Lilly, caused participants in a recent clinical study to lose more than a quarter of their body weight over 80 weeks at the highest doseresults comparable to bariatric surgery
In response, the supplement industry has rebranded its offerings to mirror the competition, down to the language it uses
PCOS Spotlight: Tirzepatide's dual GIP/GLP-1 mechanism is uniquely suited for PCOS because the GIP receptor directly improves insulin sensitivity in adipose tissue
This creates the perfect storm for sluggish bowels
Increased Alertness or Energy As the body adapts to weight loss or metabolic improvements, some individuals may feel unusually energized, making it harder to fall asleep